At PathCare, we provide clients with FDA-cleared processing technology, distributed exclusively by BIOSAFE® Switzerland. We process cord blood using the SEPAX Platform, the industry's first functionally closed, automated cord blood stem cell processing technology that is validated to process cord blood of any volume with a cell recovery rate of >95%. We are the first stem cell bank to offer this next-generation technology to families.

• Highest Cell Recovery—More Cells Lead to Better Treatment Outcomes

Having more cells available for treatment is important if you ever need them because a larger number of stem cells can help you recover faster, experience fewer complications, and, ultimately, increase your chance for survival.

By using the fully automated closed processing system saves 20% more cells on average compared to other common manual methods. With PathCare, you can be confident that you will have the greatest number of cells saved from your baby's cord blood.